Eli Lilly: Leerink Partners raises target price to $1,508.00 from $1,316.00
LLY•Leerink Partners raised its target price on Eli Lilly to $1,508.00 from $1,316.00.
LLY•Leerink Partners raised its target price on Eli Lilly to $1,508.00 from $1,316.00.
